{
  "case_id": "Case_5",
  "model_id": "mistralai/mistral-large-2411",
  "content": "```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Parkinson's Disease\",\n        \"confidence\": 0.7,\n        \"icd_code\": \"G20\",\n        \"reasoning\": \"Classic symptoms of tremor, bradykinesia, and rigidity with no family history but progressive neurological symptoms over 3 months.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Wilson's Disease\",\n            \"confidence\": 0.2,\n            \"icd_code\": \"E83.01\",\n            \"reasoning\": \"Basal ganglia abnormalities on MRI and potential environmental exposure in Bangladesh.\"\n        },\n        {\n            \"name\": \"Environmental Toxin Exposure (e.g., Manganese poisoning)\",\n            \"confidence\": 0.2,\n            \"icd_code\": \"T56.9\",\n            \"reasoning\": \"Recent travel to Bangladesh and involvement in water purification projects.\"\n        },\n        {\n            \"name\": \"Essential Tremor\",\n            \"confidence\": 0.1,\n            \"icd_code\": \"G25.0\",\n            \"reasoning\": \"Possible but less likely given the presence of bradykinesia and rigidity.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Tremor\",\n        \"Bradykinesia\",\n        \"Rigidity\",\n        \"Basal ganglia abnormalities on MRI\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Blood and Urine Tests for Heavy Metals\",\n            \"purpose\": \"Rule out environmental toxin exposure\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Ceruloplasmin and 24-hour urine copper\",\n            \"purpose\": \"Rule out Wilson's Disease\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"DAscan\",\n            \"purpose\": \"Assess dopaminergic function\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Initiate symptomatic treatment for Parkinson's Disease\",\n            \"Refer to neurology for further evaluation\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Levodopa/Carbidopa\",\n                \"dose\": \"25/100 mg\",\n                \"route\": \"PO\",\n                \"duration\": \"Indefinite\",\n                \"rationale\": \"First-line treatment for Parkinson's Disease\"\n            }\n        ],\n        \"monitoring\": [\n            \"Symptom progression\",\n            \"Monthly\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Neurology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"Specialist evaluation for Parkinson's Disease\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapid progression of symptoms\",\n        \"Development of new neurological symptoms\"\n    ],\n    \"patient_education\": [\n        \"Explanation of Parkinson's Disease and its management\",\n        \"Importance of follow-up and monitoring\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"1 month\",\n        \"conditions\": \"Worsening symptoms, new neurological symptoms\"\n    },\n    \"confidence_in_assessment\": 0.7,\n    \"uncertainties\": [\n        \"Exact nature of environmental exposure in Bangladesh\",\n        \"Potential genetic factors not yet identified\"\n    ]\n}\n```",
  "latency": 16.56471586227417,
  "timestamp": "2025-08-10T01:17:11.267256",
  "cached_at": "2025-08-10T01:17:11.267264"
}